Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Norovirus Infection
Chronic norovirus infection (CNI) causes significant morbidity in immunocompromised patients. No effective prevention or treatment currently exists. Two patients with inborn errors of immunity, X-linked severe combined immunodeficiency (X-SCID) and DOCK8 deficiency, were followed longitudinally for...
Saved in:
Published in | The Journal of infectious diseases Vol. 231; no. 3; pp. 773 - 783 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Oxford University Press
17.03.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Chronic norovirus infection (CNI) causes significant morbidity in immunocompromised patients. No effective prevention or treatment currently exists.
Two patients with inborn errors of immunity, X-linked severe combined immunodeficiency (X-SCID) and DOCK8 deficiency, were followed longitudinally for clinical course, immune reconstitution, norovirus-specific T-cell (NST) response, B-cell reconstitution, and norovirus-specific antibody production. Samples were obtained in the peri-hematopoietic stem cell transplant (HSCT) setting before and after CNI clearance. The norovirus strain causing CNI was followed longitudinally for norovirus stool viral loads and sequencing.
The noroviruses were identified as GII.4 Sydney[P4 New Orleans] in 1 patient and GII.17[P17] in the other. An exacerbation of diarrhea post-HSCT in the patient with X-SCID was consistent with norovirus infection but not with graft-versus-host disease on pathologic samples. Both patients recovered polyfunctional NSTs in the CD4 and CD8 T-cell compartments that recognized multiple norovirus structural and nonstructural viral antigens. T-cell responses were minimal during active CNI but detectable after resolution. Mapping of NST responses between the patient with DOCK8 deficiency and his matched sibling donor were nearly identical. B-cell reconstitution or new endogenous antibody production for immunoglobulin A or immunoglobulin G was not observed.
This report is the first to demonstrate reconstitution of NST immunity after HSCT closely temporally aligned with clearance of CNI, suggesting that cellular immunity is sufficient for norovirus clearance. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Report-3 ObjectType-Case Study-4 Potential conflicts of interest. M. D. K. is an author for UpToDate and is a volunteer for and co-chair of the Cellular Therapy Committee for the Pediatric Transplant and Cellular Therapy Consortium. C. M. B. is on the advisory board for Minovia TX LTD, is co-founder and on the scientific advisory boards for Catamaran Bio and Mana Therapeutics with stock and/or ownership, has stock in Neximmune and Repertoire Immune Medicines, and is on the data and safety monitoring board (DSMB) for Sobi. B. J. D. S. does ad hoc consultancy for Sobi and is on the DSMB for Orchard Therapeutics. B. A. S. is an unpaid voting member of the Molecular Genetics Subcommittee of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee and had registration for the 2024 American College of Medical Genetics Conference paid for by the American College of Medical Genetics, and is employed as a contractor by Guidehouse, Inc, to NIAID. J. C. filed a provisional patent application (62/904,856) in September 2019 covering norovirus-specific T lymphocytes. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. |
ISSN: | 0022-1899 1537-6613 1537-6613 |
DOI: | 10.1093/infdis/jiae398 |